Nitroglycerin (Glyceryl Trinitrate)

Glyceryl Trinitrate is converted to nitric oxide after administration. Nitric oxide activates the enzyme guanylate cyclase, raising cyclic GMP levels in vascular smooth muscle. This cascade causes relaxation of both veins and arteries, leading to decreased preload and afterload, which lowers myocardial oxygen demand and alleviates chest pain.

The specific dose of Nitroglycerin is determined by the prescribing clinician based on the patient’s condition, severity of symptoms, and response to therapy. Dosage may vary for acute relief versus prophylactic use, and the prescriber will provide detailed instructions tailored to each individual.

The safety of Nitroglycerin in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Nitroglycerin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Nitroglycerin belongs to the organic nitrate class, providing rapid onset of action via nitric oxide–mediated vasodilation. Compared with beta‑blockers or calcium‑channel blockers, it offers immediate relief of chest pain but may cause tolerance with continuous use, requiring drug‑free intervals. Choice of therapy depends on clinical scenario and patient tolerance.

Nitroglycerin should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, heat and direct sunlight to maintain stability. Do not store in bathrooms or near sources of humidity.

Nitroglycerin is administered sublingually, meaning the tablet or spray is placed under the tongue and allowed to dissolve without swallowing. This route provides rapid absorption into the bloodstream, delivering quick relief of angina symptoms within minutes.

The most serious risks include severe hypotension, syncope, reflex tachycardia, and rare cases of methemoglobinemia or allergic reactions such as anaphylaxis. Patients should be monitored for sudden drops in blood pressure and any signs of allergic response, especially when combined with other vasodilators.

Nitroglycerin is contraindicated in patients with known hypersensitivity to organic nitrates, those who have taken phosphodiesterase‑5 inhibitors within the past 24‑48 hours, and individuals with severe anemia or uncontrolled hypotension. Clinicians must assess each patient’s medical history before prescribing.